佐尼萨米德和其他少用抗发作药物的治疗性
Frank J E Vajda1, Terence J O'Brien2, Janet E Graham3
1Departments of Medicine and Neurosciences, The Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC 3050, Australia; Department of Neuroscience, Monash University, Melbourne, VIC 3004, Australia.
Seizure
|March 9, 2024
概括
在对澳大利亚怀孕进行的一项研究中,罕见使用的抗发作药物尼沙米德与产生的风险有关. 这种风险与怀孕早期母亲的剂量相关.
科学领域:
- 药物监督 药物监督 药物监督
- 甲状腺学 甲状腺学
- 怀孕的结果 怀孕结果
背景情况:
- 抗发作药物 (ASM) 对于在怀孕期间治疗至关重要.
- 有限的数据存在于不太常见的规定ASMs的原性风险.
- 了解这些风险对于明智的临床决策至关重要.
研究的目的:
- 评估子宫内暴露于不经常使用的ASM和子宫内发生的风险之间的关联.
- 识别可能对胎儿发育构成风险的特定ASM.
主要方法:
- 来自劳尔·瓦伦伯格澳大利亚抗药物怀孕登记册的数据分析.
- 追溯队列研究的设计.
- 统计分析以确定与特定的ASM相关的形发生风险.
主要成果:
- 尼萨米德显著与产生的风险增加有关.
- 对于其他9种不经常使用的ASM,没有发现统计学上显著的风险.
- 佐尼萨米德带来的产生的风险是剂量依赖的,与怀孕早期的暴露有关.
结论:
- 在怀孕期间使用佐尼萨米德可能会增加出生缺陷的风险.
- 佐尼萨米德,托皮拉米德和可能的阿扎胺的原性作用可能源于一种共享的类效应.
- 这些药物是硫胺衍生碳酸酶抑制剂,具有抗发作活性.
相关概念视频
Antiepileptic Drugs: Calcium Channel Blockers
393
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
393
Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
Antiepileptic Drugs: GABAergic Pathway Potentiators
399
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
399
Antiepileptic Drugs: Sodium Channel Blockers
551
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
551
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
296
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
296


